These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4629071)

  • 1. [Studies on immunological prevention of mumps. 3. Host systems of the mumps virus and their importance for development of a vaccine].
    Starke G; Hajduk F; Dietel K; Hlinak P; Rothe G
    Dtsch Gesundheitsw; 1972 Sep; 27(36):1703-9. PubMed ID: 4629071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
    Gladthe H; Abel C
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the development of a live attenuated mumps virus vaccine. I. Attenuation of the Hoshino "wild" strain of mumps virus.
    Sasaki K; Higashihara M; Inoue K; Igarashi Y; Makino S
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):43-52. PubMed ID: 828947
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on live mumps virus vaccine. 3. Evaluation of newly developed live mumps virus vaccine.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Minekawa Y
    Biken J; 1970 Sep; 13(3):157-61. PubMed ID: 4992054
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization against mumps.
    Deinhardt F; Shramek GJ
    Prog Med Virol; 1969; 11():126-53. PubMed ID: 4984708
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the development of a live attenuated mumps virus vaccine. II. Development and evaluation of the live "Hoshino" mumps vaccine.
    Makino S; Yamane Y; Sasaki K; Nagashima T; Higashihara M
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):53-62. PubMed ID: 1025341
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of live mumps virus vaccines.
    Furesz J
    J Med Virol; 2002 Jul; 67(3):299-300. PubMed ID: 12116018
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comment on: Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D: Studies of the mumps epidemic in vaccinated children in Western Switzerland].
    Gasser-Bachmann M
    Schweiz Med Wochenschr; 1997 Nov; 127(47):1970-1. PubMed ID: 9480538
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of an attenuated mumps virus vaccine. II. Immune response of animals to vaccination with inactivated and live attenuated mumps viruses.
    Shramek G; Deinhardt F
    J Immunol; 1969 Apr; 102(4):1093-8. PubMed ID: 5768187
    [No Abstract]   [Full Text] [Related]  

  • 10. Interstrain antigenic variability of mumps viruses.
    Heininger U; Bonhoeffer J
    Clin Infect Dis; 2008 Jan; 46(1):150-1. PubMed ID: 18171235
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression of established delayed hepersensitivity by mumps virus.
    Hall CB; Kantor FS
    J Immunol; 1972 Jan; 108(1):81-5. PubMed ID: 4110805
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report.
    Pagano JS; Levine RH; Sugg WC; Finger JA
    Prog Immunobiol Stand; 1967; 3():196-202. PubMed ID: 4908595
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of a study of live mumps vaccine from strain L-3 produced by the Moscow research institute for viral preparations. Characteristics of the vaccine].
    Kaptsova TI; Alekseeva AK; Gordienko NM; Rozina EE; Ermakova MN
    Vopr Virusol; 1976; (6):674-85. PubMed ID: 829008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method.
    Hosai H; Yamanishi K; Ueda S; Minekawa Y; Ogino T
    Biken J; 1970 Jun; 13(2):121-6. PubMed ID: 4990327
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nature of mumps virus intracellular inclusions].
    Nasibov MN; Smorodintsev AA
    Biull Eksp Biol Med; 1969; 67(1):51-3. PubMed ID: 4998679
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and biological properties of a new live attenuated mumps vaccine.
    Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N
    Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on live attenuated mumps virus vaccine. II. Biological characteristics of the strains adapted to the amniotic and chorioallantoic cavity of developing chick embryos.
    Yamanishi K; Hosai H; Ueda S; Takahashi M; Okuno Y
    Biken J; 1970 Jun; 13(2):127-32. PubMed ID: 4990328
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1970 May; 45(5):821-6. PubMed ID: 5444402
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of evaluating mumps vaccine effectiveness.
    Brunell P
    Clin Infect Dis; 2007 Aug; 45(4):467-9. PubMed ID: 17638195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.